Open AccessGlucagon-Like Peptide 1 Receptor Agonists and Risk of Diabetic Retinopathy Complications: Cohort Study in Nationwide Registers From Two Countries
Author(s) -
Peter Ueda,
Björn Pasternak,
Björn Eliasson,
AnnMarie Svensson,
Stefan Franzén,
Soffia Guðbjörnsdóttir,
Kristian Hveem,
Christian Jonasson,
Mads Melbye,
Henrik Svanström
Publication year - 2019
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc18-2532
Subject(s) - medicine , diabetic retinopathy , semaglutide , retinopathy , glucagon like peptide 1 receptor , diabetes mellitus , population , type 2 diabetes , ophthalmology , endocrinology , liraglutide , agonist , receptor , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom